## ITW: Illinois Tool Works Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.6% below STRENGTH zone (3.0-6.0%); PEG 3.65 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($238.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Analysts Offer Insights on Industrial Goods Companies: Leonardo Drs (DRS), Illinois Tool Works (ITW) and Compass Diversified Holdings (CODI)**
- Source: The Globe and Mail | 20251207T100906 | Neutral | Relevance: 98%
-  Analysts have recently evaluated several industrial goods companies. Austin Moeller from Canaccord Genuity maintained a Buy rating on Leonardo DRS with a $50.00 price target. Joe O’Dea from Wells Fargo maintained a Sell rating on Illinois Tool Works with a $245.00 price target, while Christopher Kennedy from William Blair maintained a Buy rating on Compass Diversified Holdings.

**2. Analysts Offer Insights on Industrial Goods Companies: Leonardo Drs (DRS), Illinois Tool Works (ITW) and Compass Diversified Holdings (CODI)**
- Source: The Globe and Mail | 20251207T100814 | Neutral | Relevance: 95%
-  Analysts have provided new ratings for several industrial goods companies. Canaccord Genuity maintained a Buy rating for Leonardo DRS (DRS) with a $50 price target. Wells Fargo maintained a Sell rating on Illinois Tool Works (ITW) with a $245 price target, while William Blair maintained a Buy rating on Compass Diversified Holdings (CODI).

**3. How Is Dover's Stock Performance Compared to Other Industrial Stocks?**
- Source: Barchart.com | 20251209T140917 | Neutral | Relevance: 73%
-  Dover Corporation (DOV) stock has outperformed the Industrial Select Sector SPDR Fund (XLI) over the past three months, rising 7.5% compared to XLI’s 2.1% gain. While DOV lags XLI year-to-date and over the past 52 weeks, the company delivered stronger-than-expected Q3 2025 operating results, leading to an 8.1% surge in its stock on October 23. Analysts maintain a “Moderate Buy” rating with a mean price target suggesting a 12.5% upside.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | B of A Securiti | $255 | $220 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | B of A Securiti | up | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.11M) |
| Sells | 2 ($1.80M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.8% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (-0.1%)
- Briar Hall Managemen: 8.9% (0.0%)
- State Farm Mutual Au: 7.2% (0.0%)
- Blackrock Inc.: 7.2% (-3.6%)
- State Street Corpora: 4.3% (-0.2%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.65 signals overvaluation risk, limited margin of safety. Forward P/E 21.8x stretched relative to 8% growth. Quality metrics strong (ROE 92%, ROA 16%, margin 19%). Analyst sentiment positive (1 raises, avg +16%). Insider selling cluster ($1.8M in 90 days), potential headwind.

| Metric | Value |
|--------|-------|
| Market Cap | $71.9B |
| Beta | 1.15 |
| 52W Range | $214.66 - $278.13 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.65 |
| Forward P/E | 21.8 |
| Current P/E | 23.6 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 4.6pp (needs >3.0% for momentum thesis). Below SMA200 (0.98x), long-term trend not supportive. RSI neutral at 48.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.57% (CS: 41) | Neutral |
| RSI_14 | 48.4 | Neutral |
| MACD Histogram | 0.49 | Bullish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 0.993x | Below |
| vs SMA200 | 0.982x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $246.63
- **Stop Loss:** $238.77 (3.2% risk)
- **Target:** $254.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 63
- **Position Value:** $15,537.69
- **Portfolio %:** 15.54%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-04 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.70 | $2.81 | +4.0% |
| 2025Q2 | $2.57 | $2.58 | +0.5% |
| 2025Q1 | $2.35 | $2.38 | +1.1% |
| 2024Q4 | $2.49 | $2.54 | +1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*